About Artificial Muscle
Artificial Muscle is a company based in Sunnyvale (United States) founded in 1999 was acquired by Bayer in March 2010. Artificial Muscle operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Vividion Therapeutics and Synthego, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Artificial Muscle
Detailed funding history for Artificial Muscle
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Artificial Muscle
Artificial Muscle has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bayer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science solutions for healthcare and agriculture are delivered.
|
Locked | Locked | Locked |
Investor details for Artificial Muscle
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artificial Muscle
Investment portfolio details for Artificial Muscle
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Artificial Muscle
Detailed financials for Artificial Muscle
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artificial Muscle Comparisons
Peer comparison for Artificial Muscle
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artificial Muscle
Artificial Muscle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Vividion Therapeutics and Synthego, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
Detailed competitors of Artificial Muscle
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artificial Muscle
Complete news archive for Artificial Muscle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artificial Muscle
Artificial Muscle was founded in 1999.
Artificial Muscle is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Art Goldberg is the current CEO of Artificial Muscle.
Artificial Muscle was founded in 1999 in Sunnyvale, United States, focusing on the materials science sector. Electroactive polymer products are developed and supplied, with proprietary technologies employed to convert electrical energy into mechanical motion. Operations center on innovation in actuators and related applications. The company was acquired by Bayer Material Science in 2010, integrating its expertise into broader material advancements.
Artificial Muscle's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Artificial Muscle has 1 investor. Key investors include Bayer.